Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05304442 · ClinicalTrials.gov registry record · Phase 3
IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department
A Phase 3 study of Anemia, Iron Deficiency and Uterine Bleeding, sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05304442: Recruiting Phase 3 study of Anemia, Iron Deficiency and Uterine Bleeding, sponsored by Baylor College of Medicine.
NCT05304442 is a Phase 3 study of Anemia, Iron Deficiency and Uterine Bleeding that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 40 participants, below the 186-participant average among 8 other Anemia, Iron Deficiency trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05304442, a Phase 3 study of Anemia, Iron Deficiency and Uterine Bleeding, is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this randomized trial is to assess the efficacy of IV Ferric Derisomaltose vs Oral Iron in the management of women with severe Iron Deficiency Anemia due to Uterine Bleeding in the emergency department.
Primary Outcome
participants will have increased hemoglobin concentrations
Conditions Studied
Interventions
- DRUG Ferric Derisomaltose 1000 Mg in 10 mL INTRAVENOUS SOLUTION [Monoferric]
- DRUG Ferrous Sulfate 65 mg elemental iron (325 mg tablets)
Study Locations (1)
Texas
- Ben Taub Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-09-15 |
| Est. Completion | 2025-04 |
| Phase | Phase 3 |
What NCT05304442 shows while recruiting
NCT05304442 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 186-participant average among 8 other Anemia, Iron Deficiency trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Anemia, Iron Deficiency appearing as the primary indexed condition, and to 2 interventions - of which Ferric Derisomaltose 1000 Mg in 10 mL INTRAVENOUS SOLUTION [Monoferric] is the first listed.
NCT05304442 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05304442 about?
NCT05304442 is a clinical study titled "IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department". The primary aim of this randomized trial is to assess the efficacy of IV Ferric Derisomaltose vs Oral Iron in the management of women with severe Iron Deficiency Anemia due to Uterine Bleeding in the emergency department.
What is the current status of trial NCT05304442?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2022-09-15. Estimated completion is 2025-04.
What conditions does trial NCT05304442 study?
This clinical trial studies the following conditions: Anemia, Iron Deficiency, Uterine Bleeding.
What interventions are being tested in trial NCT05304442?
The interventions under investigation include: Ferric Derisomaltose 1000 Mg in 10 mL INTRAVENOUS SOLUTION [Monoferric] (DRUG), Ferrous Sulfate 65 mg elemental iron (325 mg tablets) (DRUG).
Who is sponsoring clinical trial NCT05304442?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05304442 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia, Iron Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05304442's enrollment target sits among peer trials
40 8th of 8 higher than 1 of 8 other Anemia, Iron Deficiency trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia, Iron Deficiency trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
COMPLETED · Phase 3
-
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
COMPLETED · Phase 3
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
Depth of Maximal Ileal Insertion During Retrograde Enteroscopy With TTS Balloon
RECRUITING
-
Heme and Non-heme Iron Intakes, Gut Microbiota, and Influence on Host Iron Absorption
RECRUITING
-
Iron Deficiency Anemia (IDA) and the Brain
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI